How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...

Researchers have identified evidence of early Chronic Traumatic Encephalopathy (CTE) brain pathology after head impact -- even in the absence of signs of concussion. Early indicators of CTE pathology ...

Leading medical experts associated with the Sports Legacy Institute appeared Sept. 5 with Michael Benoit, father of professional wrestler Chris Benoit, to release the results of neuropathological ...